Discovery & Development

Antimicrobial resistance is an ongoing challenge for the pharmaceutical industry. What solutions can be created to address the problem?

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.

Why the industry needs to finally wake up to the real-life benefits of real-world data.

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

Can drugs change membrane protein function by altering the lipid bilayer environment? That’s what this researcher wanted to find out

SynaptixBio’s CEO discusses the personal road that led him to the fight against the rare disease H-ABC.

Can newly discovered antibodies help us do away with annual flu vaccinations?

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

Join the Curator for a look back on 12 months of top stories from cell and gene therapy’s avant garde.

Pfizer’s trial of a new medicine for COVID-19, produced with support from the US Department of Energy, could improve access to treatment.